Mohammadzadeh Reza, Saeid Harouyan Mojgan, Ale Taha Seyed Mansour
1 Department of Cell and Molecular Biology, Faculty of Basic Science, University of Maragheh, Maragheh, Iran.
2 Department of Biotechnology, Faculty of Basic Science, Islamic Azad University, Urmia, Iran.
Tumour Biol. 2017 Mar;39(3):1010428317695925. doi: 10.1177/1010428317695925.
Recently experimental validation of the networks revealed bach1, a basic leucine zipper transcription factor, as the common regulator of several functional invasive genes. The expression of bach1 and its target genes was linked to the higher risk of breast cancer recurrence in patients. The aim of this study was to investigate the effect of specific bach1 small interfering RNAs, on the invasive and expression level of miR-203, miR-145, matrix metalloproteinase-9, and CXCR4 receptor which play a role in cancer metastasis, in MDA-MB-468 cell lines.
Small interfering RNA transfection was performed with transfection regent. The survival effects of small interfering RNA were determined using trypan blue assay cells. The expression level of messenger RNA and matrix metalloproteinase-9 to assess cell invasion and the expression level of miR-203, miR-145, and CXCR4 receptor were measured by quantitative real-time polymerase chain reaction analysis on the MDA-MB-468 cell lines.
Transfection with small interfering RNA significantly suppressed the expression of bach1 gene in dose-dependent manner after 48 h ( p < 0.0001). A significant reduction in cell invasion and CXCR4 receptor, matrix metalloproteinase-9 expression were observed ( p < 0.0001). It was also a dramatic increase in the expression level of miR-203 and miR-145 ( p < 0.0001).
Our results suggest that the bach1-specific small interfering RNA effectively decrease CXCR4 receptor, matrix metalloproteinase-9 expression and breast adenocarcinoma cells invasive, also increased the expression of tumor-suppressive microRNA-203 and miR-145. Thus, these microRNAs may play a role in invasive/metastasis of carcinogenic breast cancer cells. Therefore, bach1 knockdown can be considered as a potent adjuvant in breast cancer therapy.
最近对网络的实验验证表明,碱性亮氨酸拉链转录因子巴赫1(Bach1)是几种功能性侵袭基因的共同调节因子。巴赫1及其靶基因的表达与乳腺癌患者较高的复发风险相关。本研究的目的是探讨特异性巴赫1小干扰RNA对MDA-MB-468细胞系中在癌症转移中起作用的miR-203、miR-145、基质金属蛋白酶-9和CXCR4受体的侵袭及表达水平的影响。
使用转染试剂进行小干扰RNA转染。采用台盼蓝法测定小干扰RNA对细胞的存活影响。通过定量实时聚合酶链反应分析测定MDA-MB-468细胞系中信使核糖核酸和基质金属蛋白酶-9的表达水平以评估细胞侵袭,同时测定miR-203、miR-145和CXCR4受体的表达水平。
48小时后,小干扰RNA转染以剂量依赖方式显著抑制了巴赫1基因的表达(p < 0.0001)。观察到细胞侵袭以及CXCR4受体、基质金属蛋白酶-9的表达显著降低(p < 0.0001)。miR-203和miR-145的表达水平也显著升高(p < 0.0001)。
我们的结果表明,巴赫1特异性小干扰RNA有效降低CXCR4受体、基质金属蛋白酶-9的表达及乳腺癌细胞的侵袭能力,同时增加抑癌性微小RNA-203和miR-145的表达。因此,这些微小RNA可能在致癌性乳腺癌细胞的侵袭/转移中发挥作用。所以,敲低巴赫1可被视为乳腺癌治疗中的一种有效辅助手段。